UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCEC
6751
Capital Clean Energy Carriers
CCEC
$1.35B
| $118K | ﹤0.01% |
6,454
+3,305
| +105% | +$61.7K |
|
|
CRT
6752
Cross Timbers Royalty Trust
CRT
$60.2M
| $118K | ﹤0.01% |
11,965
-12,911
| -52% | -$134K |
|
6753
SOPHiA GENETICS
SOPH
$647M
| $118K | ﹤0.01% |
38,553
+30,783
| +396% | +$105K |
|
6754
Maris-Tech
MTEK
$12.3M
| $118K | ﹤0.01% |
23,482
+17,145
| +271% | +$42.4K |
|
6755
Direxion Daily S&P 500 High Beta Bear 3X ETF
HIBS
$17.8M
| $118K | ﹤0.01% |
620
-5
| -0.8% | -$906 |
|
|
IMA
6756
ImageneBio Inc
IMA
$64.6M
| $118K | ﹤0.01% |
5,988
+5,982
| +99,700% | +$121K |
|
6757
Bit Origin
BTOG
$2.21M
| $118K | ﹤0.01% |
2,002
+1,856
| +1,271% | +$179K |
|
6758
Chemung Financial Corp
CHMG
$392M
| $117K | ﹤0.01% |
2,403
-1,039
| -30% | -$51.9K |
|
|
CXH
6759
DELISTED
MFS Investment Grade Municipal Trust
CXH
| $117K | ﹤0.01% |
14,671
-896
| -6% | -$7.28K |
|
6760
Franklin FTSE Brazil ETF
FLBR
$541M
| $117K | ﹤0.01% |
8,283
+3,629
| +78% | +$59.8K |
|
|
SPCK
6761
The SPAC and New Issue ETF
SPCK
$8.26M
| $117K | ﹤0.01% |
4,975
+4,648
| +1,421% | +$110K |
|
6762
Velocity Financial
VEL
$729M
| $117K | ﹤0.01% |
5,976
+1,450
| +32% | +$28.8K |
|
6763
Silicom
SILC
$242M
| $117K | ﹤0.01% |
7,152
+2,660
| +59% | +$37.7K |
|
6764
CuriosityStream
CURI
$161M
| $116K | ﹤0.01% |
75,807
+929
| +1% | +$1.79K |
|
6765
Amplify Travel Tech ETF
AWAY
$27M
| $116K | ﹤0.01% |
5,391
-4,307
| -44% | -$91K |
|
6766
Immuneering
IMRX
$292M
| $115K | ﹤0.01% |
52,493
+20,948
| +66% | +$43.4K |
|
|
FCTE
6767
SMI 3Fourteen Full-Cycle Trend ETF
FCTE
$249M
| $115K | ﹤0.01% |
+4,438
| New | +$120K |
|
6768
Core Alternative Capital
CCOR
$28M
| $115K | ﹤0.01% |
4,486
+4,225
| +1,619% | +$112K |
|
6769
NI Holdings
NODK
$320M
| $115K | ﹤0.01% |
7,313
+3,578
| +96% | +$56.7K |
|
6770
Landmark Bancorp
LARK
$195M
| $114K | ﹤0.01% |
4,994
-945
| -16% | -$19.5K |
|
|
BTCL
6771
T-Rex 2X Long Bitcoin Daily Target ETF
BTCL
$23.1M
| $114K | ﹤0.01% |
2,342
-8,236
| -78% | -$357K |
|
|
GRDN
6772
Guardian Pharmacy Services
GRDN
$2.78B
| $114K | ﹤0.01% |
+5,617
| New | +$116K |
|
6773
Finance of America Companies
FOA
$198M
| $114K | ﹤0.01% |
4,045
+3,724
| +1,160% | +$66.3K |
|
|
LPAAU
6774
Launch One Acquisition Corp Unit
LPAAU
| $114K | ﹤0.01% |
11,252
+1,310
| +13% | +$13.1K |
|
6775
Mobix Labs
MOBX
$26M
| $113K | ﹤0.01% |
6,669
+6,148
| +1,180% | +$62.6K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.